PRFX
NASDAQ · Pharmaceuticals
Prf Technologies Ltd
$1.47
+0.02 (+1.38%)
Open$1.47
Previous Close$1.45
Day High$1.53
Day Low$1.45
52W High$17.95
52W Low$1.28
Volume—
Avg Volume5.40M
Market Cap1.43M
P/E Ratio—
EPS$-12.92
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+713.6% upside
Current
$1.47
$1.47
Target
$11.96
$11.96
$8.59
$11.96 avg
$16.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 22.8K | 3.33M | 3.45M |
| Net Income | -6,486,477 | 722.6K | 805.0K |
| Profit Margin | -28,458.8% | 21.7% | 23.3% |
| EBITDA | -5,849,593 | 1.33M | 1.25M |
| Free Cash Flow | — | 449.2K | 396.5K |
| Rev Growth | — | -7.5% | +9.4% |
| Debt/Equity | — | 0.57 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |